• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

EVALUATE AND COMPARE INTRATHECAL PLAIN LEVOBUPIVACAINE AND DEXMEDETOMIDINE AS AN ADJUVANT TO 0.5% LEVOBUPIVACAINE FOR INFRA UMBILICAL SURGERIES

    Dr Mekala Apparao,Dr.Trishala. M. Nagaraj, Dr M Roshan Abhinav, Dr M Dheeraj Anirudh

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 11859-11869

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Spinal anesthesia is a widely used technique providing faster onset with effective and uniformly distributed sensory and motor block. Due to decreased cardiovascular and central nervous system toxicity, levobupivacaine is a good alternative for spinal anesthesia.
Aim: The aim of this study is to evaluate and compare intrathecal plain levobupivacaine and Dexmedetomidine as an adjuvant to 0.5% Levobupivacaine for infra umbilical surgeries with respect to sensory and motor blockade, hemodynamic changes, and adverse effects.
Materials and methods: This is a prospective, randomized double blinded study conducted among 60 patients who were posted under elective infra-umbilical surgery. They were equally divided into Group L: They received intrathecal 0.5% Levobupivacaine 3cc Group LD: They received intrathecal 3 mcg dexmedetomidine with 0.5% Levobupivacaine.
Results: The addition of dexmedetomidine significantly prolonged the duration of sensory and motor block. The addition of dexmedetomidine significantly prolonged the time for rescue analgesia. The addition of intrathecal dexmedetomidine lead to an early onset of sensory block. The incidence of side effects was limited to the occurrence of hypotension and bradycardia in the group that received dexmedetomidine intrathecally.
Conclusion: Intrathecal dexmedetomidine as an adjuvant to spinal anaesthesia is good choice since it produces prolonged sensory and motor block.
Keywords:
    Levobupivacaine dexmedetomidine infra umbilical surgeries
  • PDF (179 K)
  • XML
(2022). EVALUATE AND COMPARE INTRATHECAL PLAIN LEVOBUPIVACAINE AND DEXMEDETOMIDINE AS AN ADJUVANT TO 0.5% LEVOBUPIVACAINE FOR INFRA UMBILICAL SURGERIES. European Journal of Molecular & Clinical Medicine, 9(3), 11859-11869.
Dr Mekala Apparao,Dr.Trishala. M. Nagaraj, Dr M Roshan Abhinav, Dr M Dheeraj Anirudh. "EVALUATE AND COMPARE INTRATHECAL PLAIN LEVOBUPIVACAINE AND DEXMEDETOMIDINE AS AN ADJUVANT TO 0.5% LEVOBUPIVACAINE FOR INFRA UMBILICAL SURGERIES". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 11859-11869.
(2022). 'EVALUATE AND COMPARE INTRATHECAL PLAIN LEVOBUPIVACAINE AND DEXMEDETOMIDINE AS AN ADJUVANT TO 0.5% LEVOBUPIVACAINE FOR INFRA UMBILICAL SURGERIES', European Journal of Molecular & Clinical Medicine, 9(3), pp. 11859-11869.
EVALUATE AND COMPARE INTRATHECAL PLAIN LEVOBUPIVACAINE AND DEXMEDETOMIDINE AS AN ADJUVANT TO 0.5% LEVOBUPIVACAINE FOR INFRA UMBILICAL SURGERIES. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 11859-11869.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 103
  • PDF Download: 92
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus